Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

Share Price is delayed by 15 minutes
Get Live Data
2,223.00    36.00 (1.65%)
Bid:
2,222.00
Ask:
2,223.00
Spread: 1.00 (0.045%)
Market Cap: £22.50b
III Live PriceLast checked at - London Stock Exchange

Intraday 3i Group Share Chart

Annual General Meeting

18 Jul 2013 07:01

RNS Number : 5770J
3i Group PLC
18 July 2013
 



3i Group plc

18 July 2013

 

 

 

Annual General Meeting

 

At the Annual General Meeting of 3i Group plc at 11.00am this morning, Sir Adrian Montague, Chairman, will comment:

 

"Our results for the financial year to 31 March 2013 show significant improvement compared to the prior year, particularly in our Private Equity business.

 

As outlined in this morning's Interim Management Statement, we've had a strong start to the current financial year, with the NAV per share growing by 5% from 31 March 2013 to 326p per share at 30 June 2013, which reflects the continued underlying growth in earnings in the Private Equity portfolio and also a number of good realisations."

 

In the Company's Interim Management Statement relating to the three-month period from 1 April 2013 to 30 June 2013, which was released earlier this morning, Chief Executive, Simon Borrows, said that:

 

"We are making good progress in the next phase of 3i's strategic plan, transition and delivery.

 

We have enjoyed a busy run of divestment activity. The £443 million of realisations we have completed or announced in the first quarter of FY 2014 are encouraging and will support our policy to distribute 15%-20% of gross realisation proceeds. The total amount in our distribution calculation for FY 2014 so far is £665 million, including the £222 million for Mold-Masters received last year."

 

For more information, please refer to the Interim Management Statement published this morning.

 

Ends

 

 

For information, please contact:

 

 

Kathryn van der KroftCommunications Director, 3i Group plc

020 7975 3021

 

Silvia Santoro

Investor Relations Director, 3i Group plc

 

020 7975 3258

 

 

 

Notes to editors

3i is a leading international investor focused on mid-market private equity, infrastructure and debt management across Europe, Asia and the Americas.

 

For further information, please visit: www.3i.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLLFIADRIDLIV
Date   Source Headline
8th Jun 202611:21 amRNSDirector/PDMR Shareholding
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20264:24 pmRNSDirector/PDMR Shareholding
2nd Jun 20263:37 pmRNSDirector/PDMR Shareholding - Amendment
1st Jun 20264:28 pmRNSDirector/PDMR Shareholding
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:38 pmRNSAdmission to Trading
27th May 202610:42 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 202612:29 pmRNSDirector/PDMR Shareholding
21st May 20267:40 amRNSDoc re. 2026 Annual Report and Accounts
19th May 20262:28 pmRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:24 amRNSDirector/PDMR Shareholding
14th May 202610:41 amRNSHolding(s) in Company
14th May 20267:02 amRNSCommencement of Share Buyback Programme
14th May 20267:00 amRNSResults for the year to 31 March 2026
1st May 202612:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:34 pmRNSTotal Voting Rights
30th Apr 20263:31 pmRNSAdmission to Trading
7th Apr 202612:33 pmRNSHolding(s) in Company
1st Apr 20269:53 amRNSPortfolio Update
1st Apr 20269:36 amRNSDirector/PDMR Shareholding
31st Mar 20262:30 pmRNSTotal Voting Rights
31st Mar 20262:29 pmRNSAdmission to Trading
31st Mar 202611:37 amRNSDirector/PDMR Shareholding
30th Mar 20267:00 amRNSDirector/PDMR Shareholding
27th Mar 20263:07 pmRNSAdmission to Trading
26th Mar 20267:00 amRNSAction Capital Markets Seminar & portfolio update
23rd Mar 202612:11 pmRNSHolding(s) in Company
2nd Mar 202612:18 pmRNSDirector/PDMR Shareholding
27th Feb 20264:00 pmRNSTotal Voting Rights
3rd Feb 202610:20 amRNSHolding(s) in Company
3rd Feb 202610:17 amRNSDirector Declaration
30th Jan 20262:24 pmRNSDirector/PDMR Shareholding
30th Jan 20261:47 pmRNSTotal Voting Rights
29th Jan 202612:19 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSFY2026 Q3 performance update
7th Jan 20262:06 pmRNSDirector/PDMR Shareholding
6th Jan 20261:53 pmRNSTotal Voting Rights
2nd Jan 202611:06 amRNSPortfolio Update
9th Dec 20251:11 pmRNSBlock listing Interim Review
4th Dec 20252:12 pmRNSDirector/PDMR Shareholding
1st Dec 20251:25 pmRNSDirector/PDMR Shareholding
28th Nov 20254:24 pmRNSTotal Voting Rights
20th Nov 20259:59 amRNSDirector/PDMR Shareholding
18th Nov 20252:23 pmRNSDirector/PDMR Shareholding
17th Nov 202512:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.